The Director of the State Institute for Drug Control in the Czech Republic highlights the Czech pharmaceutical industry as emancipated and points out their tremendous contribution to employment, export balance, the economy at large and to the patients.
You assumed the position as interim director of the State Institute for Drug Control (SUKL) in February 2014 and were recently officially named director. What are your current priorities in order to ensure quality healthcare to the Czech population?
Despite being a relatively small market and, moreover, a country which has one of the cheapest medicines in the EU, the provision of access to medicinal products is of a very good standard here
